| actin cytoskeleton organization | GO:0030036 | 220 | 0.980 | Zebrafish Mouse Worm Fly |
| sarcomere organization | GO:0045214 | 24 | 0.976 | Zebrafish Mouse Worm Fly |
| muscle cell development | GO:0055001 | 133 | 0.972 | Zebrafish Mouse Worm Fly |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.971 | Zebrafish Mouse Worm Fly |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.958 | Fly |
| muscle contraction | GO:0006936 | 101 | 0.950 | Human Mouse Rat Worm |
| muscle system process | GO:0003012 | 141 | 0.892 | Human Mouse Rat Worm |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.886 | Human |
| transition between fast and slow fiber | GO:0014883 | 9 | 0.864 | Mouse |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.854 | Mouse |
| cardiac muscle cell development | GO:0055013 | 39 | 0.831 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.822 | Zebrafish Mouse Worm Fly |
| organelle assembly | GO:0070925 | 177 | 0.778 | Zebrafish Mouse Worm Fly |
| myosin filament organization | GO:0031033 | 3 | 0.772 | Worm |
| striated muscle cell development | GO:0055002 | 125 | 0.771 | Zebrafish Mouse Worm Fly |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.769 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.757 | Human |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.749 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.736 | Zebrafish Mouse Worm Fly |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.710 | Human |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.707 | Mouse |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.685 | Human |
| striated muscle contraction | GO:0006941 | 45 | 0.676 | Human Rat |
| muscle filament sliding | GO:0030049 | 1 | 0.667 | |
| actin myosin filament sliding | GO:0033275 | 1 | 0.656 | |
| actin filament based movement | GO:0030048 | 23 | 0.623 | |
| muscle tissue development | GO:0060537 | 308 | 0.590 | Mouse |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.584 | Human |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.576 | Human |
| striated muscle adaptation | GO:0014888 | 26 | 0.576 | Mouse |
| cardiocyte differentiation | GO:0035051 | 87 | 0.563 | |
| muscle adaptation | GO:0043500 | 39 | 0.559 | Mouse |
| nucleoside catabolic process | GO:0009164 | 206 | 0.519 | Human |
| myosin filament assembly | GO:0031034 | 2 | 0.512 | Worm |
| regulation of muscle system process | GO:0090257 | 80 | 0.511 | Human Mouse Rat Worm |
| skeletal muscle organ development | GO:0060538 | 163 | 0.501 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.500 | Mouse |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.493 | Human |
| myofibril assembly | GO:0030239 | 34 | 0.487 | Zebrafish Mouse Worm Fly |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.477 | Human |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.468 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.467 | Human |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.453 | Human |
| muscle fiber development | GO:0048747 | 76 | 0.437 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.433 | Human |
| nucleoside metabolic process | GO:0009116 | 246 | 0.424 | Human |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.424 | Mouse |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.418 | Human |
| regulation of system process | GO:0044057 | 200 | 0.416 | Human Mouse Rat Worm |
| regulation of skeletal muscle adaptation | GO:0014733 | 12 | 0.403 | Mouse |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.392 | Worm |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.386 | Human |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.372 | Human |
| heterocycle catabolic process | GO:0046700 | 280 | 0.361 | Human |
| response to inactivity | GO:0014854 | 4 | 0.359 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.355 | Human |
| actin mediated cell contraction | GO:0070252 | 15 | 0.352 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.344 | Human |
| actin filament organization | GO:0007015 | 113 | 0.339 | Fly |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.330 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.313 | Human |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.312 | Fly |
| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.305 | Fly |
| regulation of atp catabolic process | GO:1903289 | 9 | 0.305 | Human |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.303 | Human |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.301 | Human |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.293 | Human |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.293 | Human |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.293 | Human |
| skeletal muscle myosin thick filament assembly | GO:0030241 | 1 | 0.288 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.283 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.283 | Human |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.282 | Human |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.278 | Fly |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.276 | Human |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.275 | Human |
| regulation of feeding behavior | GO:0060259 | 3 | 0.274 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.272 | |
| somitogenesis | GO:0001756 | 69 | 0.269 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.265 | |
| skeletal muscle fiber adaptation | GO:0043503 | 1 | 0.265 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.263 | Human |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.255 | Human |
| cell matrix adhesion | GO:0007160 | 68 | 0.253 | |
| atp metabolic process | GO:0046034 | 75 | 0.250 | Human |
| nucleotide metabolic process | GO:0009117 | 332 | 0.248 | Human |
| regulation of muscle contraction | GO:0006937 | 49 | 0.242 | Human Rat Worm |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.234 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.231 | Human |
| striated muscle atrophy | GO:0014891 | 2 | 0.225 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.224 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.218 | Human |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.213 | Human |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.211 | Human |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.197 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.197 | Human |
| negative regulation of potassium ion transmembrane transporter activity | GO:1901017 | 3 | 0.193 | |
| myotube cell development | GO:0014904 | 60 | 0.192 | |
| cell adhesion | GO:0007155 | 329 | 0.192 | |
| regulation of heart rate | GO:0002027 | 36 | 0.191 | |
| cardiac cell development | GO:0055006 | 41 | 0.191 | |
| synaptic transmission | GO:0007268 | 329 | 0.190 | |
| heart morphogenesis | GO:0003007 | 178 | 0.184 | Mouse |
| cellular amine metabolic process | GO:0044106 | 44 | 0.181 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.178 | Human |
| calcium ion homeostasis | GO:0055074 | 127 | 0.176 | Fly |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.173 | Fly |
| protein localization to membrane | GO:0072657 | 108 | 0.168 | |
| limb morphogenesis | GO:0035108 | 149 | 0.162 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.161 | Human |
| fatty acid metabolic process | GO:0006631 | 121 | 0.160 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.158 | Human |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.158 | |
| amine metabolic process | GO:0009308 | 45 | 0.153 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.153 | Human |
| blood circulation | GO:0008015 | 195 | 0.149 | Mouse |
| cellular homeostasis | GO:0019725 | 240 | 0.148 | Fly |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.148 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.144 | |
| heart contraction | GO:0060047 | 93 | 0.142 | Mouse |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.135 | Human |
| regulation of atp metabolic process | GO:1903578 | 17 | 0.135 | Human |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.134 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.128 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.127 | Mouse |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.127 | Human |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.126 | Human |
| mitotic cell cycle | GO:0000278 | 195 | 0.126 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.125 | Human |
| segmentation | GO:0035282 | 93 | 0.124 | |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | GO:0010881 | 7 | 0.124 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.120 | Human |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.119 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.118 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.117 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.116 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.116 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.114 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.114 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.114 | |
| heart process | GO:0003015 | 94 | 0.113 | Mouse |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.112 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.112 | Human |
| regulation of atpase activity | GO:0043462 | 9 | 0.111 | Human |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.111 | Mouse |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.108 | |
| regulation of sarcomere organization | GO:0060297 | 4 | 0.108 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.105 | |
| limb development | GO:0060173 | 166 | 0.105 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.103 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.102 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.102 | |
| spemann organizer formation | GO:0060061 | 2 | 0.102 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.100 | |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0010880 | 10 | 0.098 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.097 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.097 | |
| cation homeostasis | GO:0055080 | 212 | 0.097 | Fly |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.096 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.096 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.096 | |
| response to nutrient levels | GO:0031667 | 109 | 0.095 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.094 | |
| bone development | GO:0060348 | 120 | 0.094 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.094 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.093 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.093 | |
| regulation of ion transport | GO:0043269 | 215 | 0.092 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.091 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.091 | Fly |
| peptidyl serine modification | GO:0018209 | 83 | 0.089 | |
| positive regulation of mitochondrial calcium ion concentration | GO:0051561 | 3 | 0.088 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.087 | |
| somite development | GO:0061053 | 81 | 0.087 | |
| response to starvation | GO:0042594 | 65 | 0.086 | |
| cell junction organization | GO:0034330 | 77 | 0.084 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.084 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.082 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.081 | |
| extraocular skeletal muscle development | GO:0002074 | 2 | 0.081 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.080 | |
| response to inorganic substance | GO:0010035 | 96 | 0.080 | |
| cell fate commitment | GO:0045165 | 210 | 0.078 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.077 | |
| regulation of heart growth | GO:0060420 | 31 | 0.077 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.076 | Human |
| rho protein signal transduction | GO:0007266 | 32 | 0.076 | |
| regionalization | GO:0003002 | 337 | 0.075 | |
| feeding behavior | GO:0007631 | 62 | 0.074 | |
| atp catabolic process | GO:0006200 | 55 | 0.071 | Human |
| cardiac chamber development | GO:0003205 | 108 | 0.071 | Mouse |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.070 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.069 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.069 | Mouse |
| nephric duct formation | GO:0072179 | 4 | 0.069 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.068 | |
| multi organism behavior | GO:0051705 | 62 | 0.068 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.068 | Human |
| smooth muscle contraction | GO:0006939 | 44 | 0.066 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.066 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.066 | Mouse |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.065 | |
| relaxation of muscle | GO:0090075 | 18 | 0.065 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.065 | Fly |
| cartilage development | GO:0051216 | 140 | 0.064 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.063 | |
| myotube differentiation involved in skeletal muscle regeneration | GO:0014908 | 2 | 0.063 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.063 | Fly |
| response to extracellular stimulus | GO:0009991 | 127 | 0.063 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.063 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.063 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.062 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.062 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.062 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.062 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.061 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.061 | Mouse |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.061 | |
| nuclear division | GO:0000280 | 158 | 0.061 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.060 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.060 | |
| regulation of cell motility | GO:2000145 | 236 | 0.059 | |
| tube closure | GO:0060606 | 91 | 0.059 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.059 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.059 | |
| intermediate filament bundle assembly | GO:0045110 | 3 | 0.059 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.058 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.058 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.058 | |
| body morphogenesis | GO:0010171 | 45 | 0.058 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.056 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.056 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.056 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.055 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.054 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.054 | Fly |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.054 | |
| camera type eye development | GO:0043010 | 266 | 0.054 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.053 | Human |
| somite specification | GO:0001757 | 4 | 0.053 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.052 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.052 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.051 | |
| neural tube development | GO:0021915 | 160 | 0.051 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.051 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.051 | |
| skeletal system development | GO:0001501 | 356 | 0.050 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.050 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.049 | |
| response to muscle stretch | GO:0035994 | 1 | 0.049 | |
| gas homeostasis | GO:0033483 | 3 | 0.048 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.048 | |
| microtubule based process | GO:0007017 | 236 | 0.048 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.047 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.047 | |
| associative learning | GO:0008306 | 61 | 0.047 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.047 | |
| regulation of intestinal epithelial structure maintenance | GO:0060730 | 1 | 0.047 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.047 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.046 | |
| organelle fission | GO:0048285 | 170 | 0.046 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.046 | |
| cation transport | GO:0006812 | 399 | 0.046 | |
| organelle localization | GO:0051640 | 179 | 0.046 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.045 | |
| circulatory system process | GO:0003013 | 197 | 0.045 | Mouse |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.045 | Human |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.045 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.045 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.045 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.044 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.044 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.044 | |
| mitochondrion organization | GO:0007005 | 134 | 0.044 | Fly |
| glial cell differentiation | GO:0010001 | 131 | 0.044 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.044 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.044 | |
| regulation of anagen | GO:0051884 | 1 | 0.044 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.043 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.043 | |
| pallium development | GO:0021543 | 120 | 0.043 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.043 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.043 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.043 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.043 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.042 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.042 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.042 | |
| cerebellum formation | GO:0021588 | 1 | 0.042 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.042 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.041 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.041 | |
| synapse organization | GO:0050808 | 125 | 0.041 | |
| amide transport | GO:0042886 | 138 | 0.041 | |
| positive regulation of skeletal muscle fiber development | GO:0048743 | 3 | 0.041 | |
| organ growth | GO:0035265 | 117 | 0.041 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.041 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.040 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.040 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.040 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.040 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.040 | |
| metencephalon development | GO:0022037 | 89 | 0.040 | |
| cell division | GO:0051301 | 120 | 0.040 | |
| heart growth | GO:0060419 | 45 | 0.040 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.040 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.039 | |
| cellular response to starvation | GO:0009267 | 57 | 0.039 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.039 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.039 | |
| transmembrane transport | GO:0055085 | 412 | 0.039 | |
| response to activity | GO:0014823 | 13 | 0.039 | |
| axonogenesis | GO:0007409 | 274 | 0.039 | |
| skin development | GO:0043588 | 220 | 0.039 | |
| hindbrain formation | GO:0021576 | 1 | 0.038 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.038 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.038 | |
| cartilage condensation | GO:0001502 | 18 | 0.038 | |
| gtp catabolic process | GO:0006184 | 143 | 0.038 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.038 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.038 | |
| neural tube closure | GO:0001843 | 90 | 0.038 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.037 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.037 | |
| adult behavior | GO:0030534 | 135 | 0.037 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.037 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.037 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.037 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.037 | |
| oxidation reduction process | GO:0055114 | 342 | 0.037 | |
| regulation of cardiac muscle contraction by calcium ion signaling | GO:0010882 | 9 | 0.037 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.037 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.037 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.036 | |
| negative regulation of type b pancreatic cell apoptotic process | GO:2000675 | 3 | 0.036 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.036 | |
| maintenance of location | GO:0051235 | 89 | 0.036 | Worm |
| locomotory behavior | GO:0007626 | 195 | 0.036 | |
| sa node cell action potential | GO:0086015 | 4 | 0.036 | |
| response to light stimulus | GO:0009416 | 135 | 0.036 | |
| sclerotome development | GO:0061056 | 4 | 0.036 | |
| regulation of protein localization | GO:0032880 | 231 | 0.036 | |
| lipid modification | GO:0030258 | 65 | 0.035 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.035 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.035 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.035 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.035 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.035 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.035 | |
| membrane depolarization | GO:0051899 | 64 | 0.035 | |
| amacrine cell differentiation | GO:0035881 | 5 | 0.035 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.035 | |
| deltoid tuberosity development | GO:0035993 | 3 | 0.034 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.034 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.034 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.034 | Worm |
| endodermal cell fate specification | GO:0001714 | 4 | 0.034 | |
| calcium ion transport | GO:0006816 | 159 | 0.034 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.034 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.034 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.034 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.034 | |
| extracellular structure organization | GO:0043062 | 148 | 0.034 | |
| visual behavior | GO:0007632 | 45 | 0.034 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.034 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.033 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.033 | Human Rat |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.033 | Human |
| sequestering of metal ion | GO:0051238 | 19 | 0.033 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.033 | |
| reproductive behavior | GO:0019098 | 32 | 0.033 | |
| lung development | GO:0030324 | 164 | 0.033 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.032 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.032 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.032 | Fly |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.032 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.032 | Mouse |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.031 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.031 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.031 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.031 | Human |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.031 | |
| multicellular organismal movement | GO:0050879 | 16 | 0.031 | Human |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.031 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.031 | |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0014808 | 12 | 0.031 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.030 | |
| membrane organization | GO:0061024 | 245 | 0.030 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.030 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.030 | |
| acetate ester transport | GO:1901374 | 2 | 0.030 | |
| myotube differentiation | GO:0014902 | 105 | 0.030 | |
| mitochondrial transport | GO:0006839 | 36 | 0.030 | |
| regulation of membrane repolarization | GO:0060306 | 7 | 0.030 | |
| glucose homeostasis | GO:0042593 | 128 | 0.030 | |
| multicellular organismal reproductive behavior | GO:0033057 | 23 | 0.030 | |
| potassium ion transport | GO:0006813 | 52 | 0.030 | |
| regulation of protein processing | GO:0070613 | 96 | 0.030 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.030 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.029 | |
| response to oxygen levels | GO:0070482 | 62 | 0.029 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.029 | |
| response to denervation involved in regulation of muscle adaptation | GO:0014894 | 4 | 0.029 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.029 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.029 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.029 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.029 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.029 | |
| musculoskeletal movement | GO:0050881 | 16 | 0.029 | Human |
| myeloid cell differentiation | GO:0030099 | 233 | 0.029 | |
| digestive system development | GO:0055123 | 200 | 0.029 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.029 | |
| regulation of secretion | GO:0051046 | 274 | 0.029 | |
| endomembrane system organization | GO:0010256 | 147 | 0.028 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.028 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.028 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.028 | |
| regulation of organ growth | GO:0046620 | 61 | 0.028 | |
| gtp metabolic process | GO:0046039 | 144 | 0.028 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.028 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.028 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.028 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.028 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.028 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.028 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.027 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.027 | |
| primary neural tube formation | GO:0014020 | 95 | 0.027 | |
| response to muscle inactivity | GO:0014870 | 4 | 0.027 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.027 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.027 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.027 | |
| response to metal ion | GO:0010038 | 47 | 0.027 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.027 | |
| placenta development | GO:0001890 | 140 | 0.027 | |
| regulation of phosphatidylcholine biosynthetic process | GO:2001245 | 2 | 0.027 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.027 | |
| positive regulation of schwann cell proliferation | GO:0010625 | 1 | 0.027 | |
| anion transport | GO:0006820 | 177 | 0.027 | |
| regulation of cell growth | GO:0001558 | 91 | 0.027 | |
| regulation of pinocytosis | GO:0048548 | 1 | 0.027 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.026 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.026 | |
| tongue development | GO:0043586 | 18 | 0.026 | |
| developmental cell growth | GO:0048588 | 84 | 0.026 | |
| respiratory tube development | GO:0030323 | 167 | 0.026 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.026 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.026 | |
| hindlimb morphogenesis | GO:0035137 | 42 | 0.026 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.026 | |
| appendage development | GO:0048736 | 166 | 0.026 | |
| neuron death | GO:0070997 | 154 | 0.026 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.026 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.026 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.025 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.025 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.025 | |
| ovulation cycle | GO:0042698 | 59 | 0.025 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.025 | |
| tight junction assembly | GO:0070830 | 9 | 0.025 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.025 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.025 | |
| cytokine production | GO:0001816 | 319 | 0.025 | |
| endoplasmic reticulum to cytosol transport | GO:1903513 | 12 | 0.025 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.025 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.025 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.025 | |
| forebrain development | GO:0030900 | 302 | 0.025 | |
| regulation of protein binding | GO:0043393 | 60 | 0.025 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.025 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.025 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.025 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.025 | |
| cytokinetic process | GO:0032506 | 2 | 0.025 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.025 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.025 | |
| regulation of cell size | GO:0008361 | 72 | 0.025 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.024 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.024 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.024 | |
